MAGI3 and cancer: By identifying m6A as a cis-acting epitranscriptomic mark associated with MAGI3 mRNA shortening, we have drawn an unexpected connection between large internal exon m6A modifications in MAGI3 and the expression of cancer-associated, pPA-truncated MAGI3 transcripts.